Enterprise Value Already Exists. Leadership Is About Connecting It.
Growth creates opportunity. Connection creates enterprise value.
The Executive Question
Growth remains one of the defining ambitions of every healthcare and life sciences company.
Some organisations pursue organic growth through innovation, portfolio expansion and geographic reach. Others accelerate growth through acquisitions, licensing agreements and strategic partnerships. Most successful companies combine these approaches throughout their evolution.
Yet while growth creates new opportunities, it does not automatically create enterprise value.
A more important question is often overlooked.
How effectively are capabilities connected after they are created, acquired or combined?
Growth Creates Capability. Leadership Creates Value.
Every growth strategy is ultimately an investment in capability.
Organic growth develops scientific expertise, digital capabilities, manufacturing capacity and commercial excellence.
Acquisitions introduce products, technologies, talent and market access.
Strategic partnerships provide complementary expertise that would otherwise take years to develop.
Each of these strengthens an enterprise.
None of them, however, guarantees enterprise value.
Enterprise value emerges only when these capabilities work together towards a common objective.
Leadership is therefore not simply about deciding where to grow.
It is about ensuring that growth becomes greater than the sum of its individual parts.
From the Field
Across the pharmaceutical industry, commercial rights to medicines regularly change hands.
The product itself often remains unchanged. Its formulation, clinical evidence and regulatory approval remain the same.
When a pharmaceutical company acquires or licenses a product that no longer aligns with the strategic priorities of its previous owner, the transaction alone rarely creates enterprise value.
Value is created afterwards through sharper positioning, stronger market access, focused medical engagement, reliable supply, disciplined commercial execution and thoughtful lifecycle management.
The medicine has not changed.
The science has not changed.
The enterprise surrounding the product has.
The lesson extends far beyond pharmaceutical products. Whether integrating an acquisition, launching a new medicine or expanding internationally, ownership transfers an asset; leadership determines its value.
Looking Beyond the Organisation
Healthcare is unlike most industries.
Success is rarely created by excellence in a single function alone. In my experience, it more often emerges when capabilities that already exist across an enterprise—and sometimes across multiple organisations—are intentionally brought together around a common purpose. What those connections look like will differ from one organisation to another. They may involve aligning scientific innovation with commercial opportunity, integrating medical, regulatory, market access and commercial expertise earlier in the medicine lifecycle, strengthening the relationship between manufacturing and supply resilience, or combining digital capabilities with better decision-making. In other situations, the greatest opportunity lies in bringing together internal expertise with external partners across the healthcare ecosystem. There is no universal model. The common principle is that enterprise value often becomes more visible when people, capabilities, technologies and decisions are aligned behind a shared objective.
Ultimately, patients, clinicians, pharmacists, payors and healthcare systems do not experience individual departments or companies. They experience one connected healthcare journey.
When these connections are strong, innovation reaches patients faster, clinicians are better supported, reimbursement discussions become more effective and healthcare systems realise greater value.
When they are weak, opportunities are delayed, fragmented or lost—even when every individual function performs well.
Enterprise value is therefore created not only through excellence within companies, but through excellence across the healthcare ecosystem.
Leadership Implication
Leaders spend considerable time deciding what to acquire, what to build and where to invest.
These remain essential strategic decisions.
An equally important question is asked far less frequently.
Which capabilities already exist within our enterprise—or across our network of partners—that are not yet creating their full value because they remain disconnected?
For organisations that have grown through acquisitions, the answer may lie between portfolios or business units.
For organisations pursuing organic growth, it may lie between functions.
For organisations operating internationally, it may lie between regions, partners or healthcare systems.
Wherever those connections are missing, unrealised enterprise value is likely to exist.
Closing Perspective
Healthcare has never possessed greater scientific knowledge, technological capability or innovative potential.
The organisations that will define the next decade are unlikely to be those that simply accumulate more assets, technologies or capabilities.
They will be those that connect them more effectively.
Not only within their own enterprise, but across the broader healthcare ecosystem.
Because sustainable enterprise value is rarely created by a single capability.
It emerges when capabilities are intentionally connected to improve outcomes for patients, support healthcare professionals, strengthen healthcare systems and create lasting value for society.
NexThera Perspectives shares concise leadership perspectives for healthcare executives, boards and investors. Each Perspective is grounded in healthcare practice and informed by experience across the medicine lifecycle.